DK1771191T3 - Præparat til anvendelse af aspartat og B12-vitamin eller biotin til regulering af ketonstoffer - Google Patents

Præparat til anvendelse af aspartat og B12-vitamin eller biotin til regulering af ketonstoffer

Info

Publication number: DK1771191T3
Authority: DK; Denmark
Prior art keywords: aspartate; biotin; vitamin; preparation; control
Prior art date: 2004-07-19

Application number

DK05762925.5T

Other languages

English (en)

Inventor

Robert Johan Joseph Hageman

Original Assignee

Nutricia Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-07-19

Filing date

2005-07-18

Publication date

2014-06-10

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35714682&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1771191(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-07-18 Application filed by Nutricia Nv filed Critical Nutricia Nv

2014-06-10 Application granted granted Critical

2014-06-10 Publication of DK1771191T3 publication Critical patent/DK1771191T3/da

Links

YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 title 2
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 title 1
229930003779 Vitamin B12 Natural products 0.000 title 1
229940009098 aspartate Drugs 0.000 title 1
235000020958 biotin Nutrition 0.000 title 1
239000011616 biotin Substances 0.000 title 1
229960002685 biotin Drugs 0.000 title 1
FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 title 1
150000002576 ketones Chemical class 0.000 title 1
239000000126 substance Substances 0.000 title 1
239000011715 vitamin B12 Substances 0.000 title 1
235000019163 vitamin B12 Nutrition 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L13/00—Meat products; Meat meal; Preparation or treatment thereof
- A23L13/40—Meat products; Meat meal; Preparation or treatment thereof containing additives
- A23L13/42—Additives other than enzymes or microorganisms in meat products or meat meals
- A23L13/424—Addition of non-meat animal protein material, e.g. blood, egg, dairy products, fish; Proteins from microorganisms, yeasts or fungi
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L13/00—Meat products; Meat meal; Preparation or treatment thereof
- A23L13/60—Comminuted or emulsified meat products, e.g. sausages; Reformed meat from comminuted meat product
- A23L13/65—Sausages
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L23/00—Soups; Sauces; Preparation or treatment thereof
- A23L23/10—Soup concentrates, e.g. powders or cakes
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/185—Vegetable proteins
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Natural Medicines & Medicinal Plants (AREA)
Mycology (AREA)
Nutrition Science (AREA)
Food Science & Technology (AREA)
Polymers & Plastics (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Microbiology (AREA)
Diabetes (AREA)
Medical Informatics (AREA)
Botany (AREA)
Biotechnology (AREA)
Alternative & Traditional Medicine (AREA)
Molecular Biology (AREA)
Immunology (AREA)
Hematology (AREA)
Obesity (AREA)
Endocrinology (AREA)
Pediatric Medicine (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Emergency Medicine (AREA)
Reproductive Health (AREA)
Pain & Pain Management (AREA)
Urology & Nephrology (AREA)

DK05762925.5T 2004-07-19 2005-07-18 Præparat til anvendelse af aspartat og B12-vitamin eller biotin til regulering af ketonstoffer DK1771191T3 (da)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US58879304P	2004-07-19	2004-07-19
EP04077100		2004-07-19
EP04077359		2004-08-20
PCT/NL2005/000520 WO2006009438A2 (en)	2004-07-19	2005-07-18	Preparation for use of aspartate and vitamin b12 or biotin for regulating ketone bodies

Publications (1)

Publication Number	Publication Date
DK1771191T3 true DK1771191T3 (da)	2014-06-10

Family

ID=35714682

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK13152810.1T DK2705849T3 (da)	2004-07-19	2005-07-18	Præparat til anvendelse af aspartat til regulering af glucoseniveauer i blod
DK05762925.5T DK1771191T3 (da)	2004-07-19	2005-07-18	Præparat til anvendelse af aspartat og B12-vitamin eller biotin til regulering af ketonstoffer

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
DK13152810.1T DK2705849T3 (da)	2004-07-19	2005-07-18	Præparat til anvendelse af aspartat til regulering af glucoseniveauer i blod

Country Status (13)

Country	Link
US (5)	US8003600B2 (da)
EP (3)	EP1771192B1 (da)
JP (2)	JP2008506771A (da)
CN (3)	CN101018561A (da)
BR (2)	BRPI0513551A (da)
CA (2)	CA2574423A1 (da)
DK (2)	DK2705849T3 (da)
ES (3)	ES2673195T3 (da)
NZ (1)	NZ552706A (da)
PL (3)	PL1771192T3 (da)
RU (1)	RU2633071C2 (da)
TR (1)	TR201809368T4 (da)
WO (2)	WO2006009437A2 (da)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2006009437A2 (en) *	2004-07-19	2006-01-26	N.V. Nutricia	Use of aspartate for regulating glucose levels in blood
US20070207187A1 (en) *	2004-09-29	2007-09-06	Mizuo Yajima	Functional Composition Or Food Comprising Whey Protein, Antibody Derived From Milk Or Antibody
EP1853246A1 (en) *	2005-02-17	2007-11-14	Instituto del Metabolismo Celular, S.L.	L-aspartic acid for the treatment of problems in connection with the fat or glucose metabolism
EP1774973A1 (en) *	2005-10-12	2007-04-18	Nutricia N.V.	Leucine rich composition
WO2008054192A1 (en) *	2006-11-02	2008-05-08	N.V. Nutricia	Use of nutritional compositions for preventing disorders
ATE509624T1 (de) *	2005-12-23	2011-06-15	Nutricia Nv	Zusammensetzung enthaltend mehrfach ungesättigte fettsäuren, proteine, mangan und/oder molybden und nukleotide/nukleoside, zur behandlung von demenz
RU2414905C2 (ru) *	2005-12-23	2011-03-27	Н.В. Нютрисиа	Применение питательных композиций с фосфолипидами, сфинголипидами и холестерином
CA2646672A1 (en) *	2006-03-23	2007-09-27	Nestec S.A.	High-calorie nutritional supplement
CA2665164A1 (en) *	2006-10-06	2008-05-15	Nestec S.A.	Compositions and multiplex assays for measuring biological mediators of physiological health
WO2008054193A1 (en)	2006-11-02	2008-05-08	N.V. Nutricia	Nutritional products that comprise saccharide oligomers
ES2363118T3 (es)	2007-10-02	2011-07-20	Isme Privates Forschungsinstitut Für Sport, Medizin Und Ernährung Gmbh	Nutrimiento para uso para la mejora acelerada del comportamiento fisiológico.
US8651126B2 (en)	2007-11-21	2014-02-18	Teva Pharmaceutical Industries, Ltd.	Controllable and cleanable steam trap apparatus
WO2010002242A1 (en)	2008-07-02	2010-01-07	N.V. Nutricia	Nutritional composition for improving muscle function and daily activity
CA2676518A1 (en) *	2008-08-29	2010-02-28	Kraft Foods Global Brands Llc	Whey protein pre-load
MX2011002983A (es) *	2008-09-19	2011-04-11	Nestec Sa	Soporte nutricional para prevenir o moderar la paralisis de medula osea o neutropenia durante el tratamiento anti-cancer.
WO2010104374A1 (en) *	2009-03-09	2010-09-16	N.V. Nutricia	Nutritional composition inducing a postprandial endocrine response
WO2010112060A1 (en) *	2009-03-30	2010-10-07	Isme Privates Forschungsinstitut Für Sport, Medizin Und Ernährung Gmbh	Nutriment for use for accelerated physiological perfomance enhancement
PL2413718T3 (pl)	2009-04-01	2017-08-31	Nestec S.A.	Zastosowanie kwasu arachidonowego do zmniejszenia ryzyka insulinooporności w późniejszym życiu
US8703719B1 (en) *	2009-05-18	2014-04-22	Bio-Engineered Supplements And Nutrition, Inc.	Method and composition for improved muscle performance
WO2011021926A1 (en) *	2009-08-21	2011-02-24	N.V. Nutricia	Regulating the amino acid pool used for the acute-phase protein synthesis
WO2012074375A1 (en) *	2010-12-01	2012-06-07	N.V. Nutricia	Prevention or treatment of overweight and obesity in type 2 diabetic patients
BR112013025047A2 (pt) *	2011-03-31	2017-02-14	Nestec Sa	composições nutricionais para aumentar os níveis de arginina e métodos para usar as mesmas
US20140107193A1 (en) *	2011-10-14	2014-04-17	Mead Johnson Nutrition Company	Nutritional composition containing a neurologic component of kaempferol and/or fisetin and uses thereof
SG11201502205SA (en) *	2012-09-21	2015-04-29	Abbott Lab	Nutritional compositions including calcium beta-hydroxy-beta-methylbutyrate, protein and low levels of electrolytes
US10668037B2 (en) *	2012-12-06	2020-06-02	Bio Health Solutions, Llc	Treatment for chronic kidney disease
US9669010B2 (en) *	2012-12-06	2017-06-06	Bio Health Solutions, Llc	Treatment for chronic kidney disease
WO2014125099A1 (en) *	2013-02-15	2014-08-21	Nestec S.A.	Food composition and its use
SI3287133T1 (sl)	2013-06-05	2019-09-30	Tricida Inc.	Polimeri, ki vežejo protone,za peroralno dajanje
US9226914B2 (en) *	2013-07-16	2016-01-05	Mead Johnson Nutrition Company	Methods for promoting neuronal development and/or health
US9241923B2 (en) *	2013-07-16	2016-01-26	Mead Johnson Nutrition Company	Methods for promoting neuronal development and/or health
US10709770B2 (en) *	2013-07-31	2020-07-14	Mead Johnson Nutrition Company	Nutritional compositions containing a prebiotic and lactoferrin and uses thereof
US9609888B2 (en) *	2013-07-31	2017-04-04	Mead Johnson Nutrition Company	Nutritional compositions containing synergistic combination and uses thereof
US20150119322A1 (en) *	2013-07-31	2015-04-30	Mead Johnson Nutrition Company	Nutritional compositions containing a prebiotic and lactoferrin and uses thereof
US20150164833A1 (en) *	2013-12-17	2015-06-18	Mead Johnson Nutrition Company	Nutritional composition containing a neurologic component of ursolic acid and uses thereof
EP3593808B1 (en)	2014-12-10	2020-12-09	Tricida Inc.	Proton-binding polymers for oral administration
WO2016205754A1 (en)	2015-06-19	2016-12-22	University Of Southern California	Compositions and methods for modified nutrient delivery
WO2016205701A1 (en)	2015-06-19	2016-12-22	University Of Southern California	Enteral fast access tract platform system
BR112018072714A2 (pt)	2016-05-06	2019-02-19	Tricida, Inc.	composições de ligação a hcl para e método de tratamento de distúrbios de ácido-base
JOP20190146A1 (ar)	2016-12-19	2019-06-18	Axcella Health Inc	تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
RU2644355C1 (ru) *	2017-04-17	2018-02-09	федеральное государственное автономное образовательное учреждение высшего образования "Казанский (Приволжский) федеральный университет" (ФГАОУ ВО КФУ)	Соединения на основе пиридоксина, обладающие способностью активировать фермент глюкокиназу
EP3668499A1 (en)	2017-08-14	2020-06-24	Axcella Health Inc.	Amino acid compositions for the treatment of liver disease
US10466256B2 (en)	2017-11-03	2019-11-05	Lysulin, Inc.	Inhibiting chronic blood and nephrological disorders using lysine-based supplements
US10610544B2 (en)	2017-11-03	2020-04-07	Lysulin, Inc.	Insulin resistance and beta cell function using lysine-based supplements
US11255838B2 (en)	2017-11-03	2022-02-22	Lysulin, Inc.	Levels, functions, and resistances related to chronic conditions by using lysine-based supplements
SG11202003451UA (en)	2017-11-03	2020-05-28	Tricida Inc	Compositions for and method of treating acid-base disorders
US10653720B2 (en) *	2017-11-03	2020-05-19	Lysulin, Inc.	Prevention of protein glycation using lysine/zinc supplements
US11197917B2 (en)	2017-12-01	2021-12-14	ByHeart, Inc.	Formulations for nutritional support in subjects in need thereof
WO2019246225A1 (en)	2018-06-20	2019-12-26	Axcella Health Inc.	Compositions and methods for the treatment of fat infiltration in muscle
CN110655567B (zh) *	2019-11-12	2021-07-09	云南大学	食品蛋白的磷酸化方法及其磷酸化蛋白
CA3163526A1 (en) *	2019-12-05	2021-06-10	Flagship Pioneering Innovations V, Inc.	Acylated active agents and methods of their use for the treatment of metabolic disorders and nonalcoholic fatty liver disease
KR20250091590A (ko) *	2023-12-14	2025-06-23	의료법인 성광의료재단	아스파르트산을 포함하는 말초동맥질환의 예방 또는 치료용 약학적 조성물

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US1560000A (en)	1924-08-15	1925-11-03	Beatrice Sanville	Garment button
US4138498A (en) *	1976-12-07	1979-02-06	W. R. Grace & Co.	Ruminant feed additive
US5116819A (en)	1989-05-05	1992-05-26	Clintec Nutrition Co.	Enteral diet for patients with pulmonary disease
FR2657013B1 (fr)	1990-01-18	1992-05-15	Medgenix Group Sa	Composition dietetique a base de polypeptides et acides amines.
US5292773A (en)	1990-02-14	1994-03-08	Hirsch Gerald P	Treating aids and HIV infection with methionine
US5356873A (en) *	1992-11-05	1994-10-18	Clintec Nutrition Co.	Method for providing nutritional requirements to patients having a chronic inflammation reaction
ES2173109T3 (es) *	1992-12-23	2002-10-16	Abbott Lab	Alimentos de unso medico destinados parael sostenimiento nutricional de recien nacidos/de bebes que padecen enfermedades metabolicas.
US5470839A (en)	1993-04-22	1995-11-28	Clintec Nutrition Company	Enteral diet and method for providing nutrition to a diabetic
GB9312369D0 (en) *	1993-06-16	1993-07-28	Sandoz Nutrition Ltd	Organic compounds
US5438042B1 (en) *	1993-10-08	1997-08-26	Sandoz Nutrition Ltd	Enteral nutritional composition having amino acid profile
AU682894B2 (en)	1993-10-28	1997-10-23	Institut National De La Recherche Agronomique	Composition based on amino acids intended for the treatment of sepsis or of an attack bringing about an inflammatory reaction, in animals and man
US5576287A (en) *	1994-04-29	1996-11-19	Wake Forest University	Method for treating acute renal disease and failure
GB9409646D0 (en)	1994-05-13	1994-07-06	Scient Hospital Suppl Int Ltd	Nutritional formulation
US5550166A (en) *	1995-03-17	1996-08-27	Ostlund; Richard E.	Pinitol and derivatives thereof for the treatment of metabolic disorders
JPH0965836A (ja) *	1995-08-31	1997-03-11	Hokuren Federation Of Agricult Coop:The	α−グルコシダーゼ阻害剤、それを含む糖組成物、甘味料、食品及び飼料
MY115050A (en)	1995-10-16	2003-03-31	Mead Johnson Nutrition Co	Diabetic nutritional product having controlled absorption of carbohydrate
CN1218371A (zh)	1996-05-13	1999-06-02	吉斯特·布罗卡迪斯股份有限公司	新的食品组合物
DE19632452C1 (de) *	1996-08-12	1998-02-19	Cpc International Inc	Würzsauce, Verfahren zu deren Herstellung und deren Verwendung
EP0920321A1 (de) *	1996-08-26	1999-06-09	Oswald Wiss	Vitaminpräparate mit sauerstoffsparender wirkung bei körperlicher leistung
DE19701382A1 (de)	1997-01-16	1998-07-23	Nutricia Nv	Kohlenhydratmischung
US6042834A (en) *	1997-01-29	2000-03-28	Baraka; Mohamed Wasif	Herbal composition for diabetes and method of treatment
US5922766A (en)	1997-07-02	1999-07-13	Acosta; Phyllis J. B.	Palatable elemental medical food
RU2145869C1 (ru) *	1999-04-30	2000-02-27	Орещенко Андрей Владимирович	Способ антимутагенного воздействия на организм
CA2274414A1 (en)	1999-06-11	2000-12-11	Universite Laval	Dietary fish protein for use in restoring normal insulin function insulin-resistant individuals
US6312755B1 (en) *	1999-07-16	2001-11-06	Ampc	Whey treatment process for achieving high concentration of α-lactalbumin
GB9927603D0 (en) *	1999-11-22	2000-01-19	Nestle Sa	Use of a milk protein hydrolysate in the treatment of diabetes
GB9929497D0 (en) *	1999-12-14	2000-02-09	Vitaflo Limited	Improved amino acid mixtures for the treatment and/or management of certain diseases
ZA200109677B (en) *	2000-09-06	2002-06-25	Technikon Pretoria	A nutritional and pharmaceutical composition.
US20040043013A1 (en)	2000-12-28	2004-03-04	Mccleary Edward Larry	Metabolic uncoupling therapy
US6743770B2 (en)	2001-02-14	2004-06-01	Functional Foods, Inc.	Nutritional supplement for the management of stress
CN1193691C (zh) *	2001-02-28	2005-03-23	陈胜利	中老年人养生保健饮料及制备方法
US6720312B2 (en)	2001-03-16	2004-04-13	Heartland Health Solutions, Llc	Method for controlling the membrane structure of a starch granule
US20030000391A1 (en)	2001-06-12	2003-01-02	Jay Highman	Organic nutritional formula
US20040234631A1 (en)	2001-07-03	2004-11-25	Hoie Lars Henrik	Composition comprising soy and use thereof in the provention and/or treatment of various diseases
US6503530B1 (en)	2001-11-01	2003-01-07	Chunghee Kimberly Kang	Method of preventing development of severe metabolic derangement in inborn errors of metabolism
US20030118663A1 (en) *	2001-12-24	2003-06-26	Ching-Ming Chang	Method and composition for treating diabetes
US6916796B2 (en)	2002-06-12	2005-07-12	Abbott Laboratories	Use of pullulan as a slowly digested carbohydrate
GB0213612D0 (en) *	2002-06-13	2002-07-24	Novartis Nutrition Ag	Organic compounds
GB0221184D0 (en)	2002-09-13	2002-10-23	Cerestar Holding Bv	Carbohydrate materials in food and drink compositions
US6706697B1 (en) *	2002-09-19	2004-03-16	Jason Pharmaceuticals, Inc.	Diabetic nutrition and weight loss drink compositions
JP2006510367A (ja) *	2002-12-20	2006-03-30	ユニリーバー・ナームローゼ・ベンノートシヤープ	血糖調節組成物
WO2006009437A2 (en) *	2004-07-19	2006-01-26	N.V. Nutricia	Use of aspartate for regulating glucose levels in blood

2005
- 2005-07-18 WO PCT/NL2005/000519 patent/WO2006009437A2/en not_active Ceased
- 2005-07-18 EP EP05762926.3A patent/EP1771192B1/en not_active Revoked
- 2005-07-18 CN CNA2005800304665A patent/CN101018561A/zh active Pending
- 2005-07-18 CN CN201310722533.6A patent/CN103734746B/zh not_active Expired - Lifetime
- 2005-07-18 BR BRPI0513551-6A patent/BRPI0513551A/pt not_active Application Discontinuation
- 2005-07-18 US US11/572,197 patent/US8003600B2/en not_active Expired - Fee Related
- 2005-07-18 NZ NZ552706A patent/NZ552706A/en not_active IP Right Cessation
- 2005-07-18 PL PL05762926T patent/PL1771192T3/pl unknown
- 2005-07-18 PL PL05762925T patent/PL1771191T3/pl unknown
- 2005-07-18 CN CN200580031377.2A patent/CN101022821B/zh not_active Expired - Lifetime
- 2005-07-18 JP JP2007522447A patent/JP2008506771A/ja active Pending
- 2005-07-18 ES ES13152810.1T patent/ES2673195T3/es not_active Expired - Lifetime
- 2005-07-18 CA CA002574423A patent/CA2574423A1/en not_active Abandoned
- 2005-07-18 US US11/632,871 patent/US8501676B2/en not_active Expired - Fee Related
- 2005-07-18 RU RU2010140355A patent/RU2633071C2/ru active
- 2005-07-18 TR TR2018/09368T patent/TR201809368T4/tr unknown
- 2005-07-18 ES ES05762925.5T patent/ES2467093T3/es not_active Expired - Lifetime
- 2005-07-18 DK DK13152810.1T patent/DK2705849T3/da active
- 2005-07-18 CA CA002574360A patent/CA2574360A1/en not_active Abandoned
- 2005-07-18 DK DK05762925.5T patent/DK1771191T3/da active
- 2005-07-18 BR BRPI0513500-1 patent/BRPI0513500C8/pt active IP Right Grant
- 2005-07-18 ES ES05762926T patent/ES2700463T3/es not_active Expired - Lifetime
- 2005-07-18 WO PCT/NL2005/000520 patent/WO2006009438A2/en not_active Ceased
- 2005-07-18 PL PL13152810T patent/PL2705849T3/pl unknown
- 2005-07-18 JP JP2007522448A patent/JP2008506772A/ja active Pending
- 2005-07-18 EP EP13152810.1A patent/EP2705849B1/en not_active Revoked
- 2005-07-18 EP EP05762925.5A patent/EP1771191B1/en not_active Revoked
2011
- 2011-08-01 US US13/195,831 patent/US8865649B2/en not_active Expired - Fee Related
2013
- 2013-07-15 US US13/941,625 patent/US9889149B2/en not_active Expired - Fee Related
2014
- 2014-10-16 US US14/516,129 patent/US9539278B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
WO2006009437A3 (en)	2006-04-06
EP1771192A2 (en)	2007-04-11
CA2574360A1 (en)	2006-01-26
US20140161928A1 (en)	2014-06-12
EP1771192B1 (en)	2018-09-12
US20150038453A1 (en)	2015-02-05
WO2006009438A2 (en)	2006-01-26
US8501676B2 (en)	2013-08-06
PL1771191T3 (pl)	2014-08-29
JP2008506772A (ja)	2008-03-06
ES2673195T3 (es)	2018-06-20
CN101022821B (zh)	2014-01-29
US9889149B2 (en)	2018-02-13
WO2006009438A3 (en)	2006-09-14
BRPI0513500C8 (pt)	2022-06-14
US8003600B2 (en)	2011-08-23
RU2010140355A (ru)	2012-04-10
CA2574423A1 (en)	2006-01-26
CN103734746A (zh)	2014-04-23
BRPI0513500B1 (pt)	2021-03-09
ES2467093T3 (es)	2014-06-11
US8865649B2 (en)	2014-10-21
EP2705849A3 (en)	2014-10-15
EP1771191A2 (en)	2007-04-11
CN101018561A (zh)	2007-08-15
PL1771192T3 (pl)	2019-02-28
JP2008506771A (ja)	2008-03-06
EP1771191B1 (en)	2014-03-12
EP2705849A2 (en)	2014-03-12
BRPI0513500B8 (pt)	2022-05-24
TR201809368T4 (tr)	2018-07-23
BRPI0513551A (pt)	2008-05-06
US20080269117A1 (en)	2008-10-30
RU2633071C2 (ru)	2017-10-11
US20110288016A1 (en)	2011-11-24
BRPI0513500A (pt)	2008-05-06
WO2006009437A2 (en)	2006-01-26
US9539278B2 (en)	2017-01-10
US20080032916A1 (en)	2008-02-07
ES2700463T3 (es)	2019-02-15
PL2705849T3 (pl)	2018-09-28
CN103734746B (zh)	2017-01-11
NZ552706A (en)	2011-01-28
DK2705849T3 (da)	2018-05-22
EP2705849B1 (en)	2018-04-04
CN101022821A (zh)	2007-08-22

Publication	Publication Date	Title
DK1771191T3 (da)	2014-06-10	Præparat til anvendelse af aspartat og B12-vitamin eller biotin til regulering af ketonstoffer
DK2188336T3 (da)	2013-12-02	Sammensætning omfattende et eller flere hydrofobt modificerede polyacrylamider og fremgangsmåde til anvendelse af sammensætningen
DK3095447T3 (da)	2022-01-31	Behandling af vitamin d-insufficiens og -mangel med 25-hydroxyvitamin d2 og 25-hydroxyvitamin d3
FI20050867L (fi)	2007-03-01	Menetelmä ja kutsujärjestelmä
DK1951866T3 (da)	2014-10-27	Delta-9-elongaser og anvendelse heraf til fremstilling af flerumættede fedtsyrer
DK1805312T3 (da)	2009-10-19	Fremgangsmåder og midler til fremstilling af hyaluronan
DK1755743T3 (da)	2013-06-10	Beta-hydroxybutyrat og derivater til behandling af depression og angst
DK2099596T3 (da)	2013-01-02	Formværktøj til den grunddannende eller omdannende formgivning ag byggeelementer af termisk influerbare materialer
SE0702458L (sv)	2007-11-08	Styrsystem och -metod
DK1773361T4 (da)	2012-10-15	Sammensætning baseret på probiotiske bakterier og anvendelse deraf til forebyggelse og/eller behandling af respiratoriske sygdomme
IL188680A0 (en)	2008-08-07	Microfluidic devices and methods of preparing and using the same
GB0706150D0 (en)	2007-05-09	Gradient scaffolding and methods of producing the same
DK2044076T3 (da)	2010-02-01	Fremgangsmåde til fremstilling af asenapin og intermediatprodukter, som anvendes i fremgangsmåden
DK1773133T3 (da)	2009-02-02	Fremgangsmåder til fremstilling af plantestofekstrakter og fodersammensætninger til kæledyr
FI20055214L (fi)	2006-11-07	Levy, sen käyttö, järjestelmä ja levyn kiinnitysmenetelmä
IL185966A0 (en)	2008-02-09	Phytoplankton-based nutraceuticals and method of obtaining the same
DK1689720T3 (da)	2009-08-10	Pyrazolyl-derivater i form af medikamenter til behandling af akutte eller kroniske tilstande med neuronal degeneration
DK1922309T3 (da)	2014-08-25	N-phenyl-2-pyrimidin-aminderivater og fremgangsmåde til fremstillingen deraf
DE602005001520D1 (de)	2007-08-16	Zeiteinstellungssystem und Zeiteinstellungsverfahren
BRPI0817332A2 (pt)	2015-03-24	Composição e método de ingrediente sensível estabilizado.
IL185723A0 (en)	2008-01-06	Controlled release pharmaceutical compositions of liothyronine and methods of making and using the same
DK2193789T3 (da)	2013-05-21	Anvendelse af 3,5-dihydroxytoluen eller derivater deraf i fremstillingen af medicin og funktionelle fødevarer til behandling eller forebyggelse af depression
DK4070800T3 (da)	2025-01-02	Cladribinkur til behandling af multipel sklerose
NO20051432L (no)	2005-09-26	Komposittplate for ortopediteknikken, fremgangsmate til dens fremstilling og dens anvendelse
EP1859826A4 (en)	2013-05-29	CONTRAST REMOVAL SYSTEM AND METHOD FOR ACTIVATING THE CONTRAST REMOVAL SYSTEM